Skip to content

BIVIT: what changed

BE 0439.165.025NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparationsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€368,404
2024 · €392,283-€23,880
Equity
€780,157
2024 · €779,754+€404
Cash
€118,505
2024 · €114,569+€3,936
Balance sheet total
€4.4m
2024 · €4.1m+€237,790

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€394,357

    up €394,357 (+35.8%), from €1.1m to €1.5m

    of which Plant, machinery and equipment: +€540,022

  • Receivables within one year -€287,483

    down €287,483 (-16.5%), from €1.7m to €1.5m

    of which Trade receivables: -€377,966

  • Deferred charges and accrued income +€72,999

    up €72,999 (+114%), from €64,279 to €137,278

Equity and liabilities
  • Debts after one year +€474,499

    up €474,499 (+127%), from €372,545 to €847,045

  • Trade debts -€257,057

    down €257,057 (-12.5%), from €2.1m to €1.8m

  • Accrued charges and deferred income -€90,236

    down €90,236 (-40.0%), from €225,343 to €135,107

  • Tax, wage and social debts +€73,356

    up €73,356 (+30.1%), from €243,571 to €316,927

    of which Taxes: +€53,392

  • Current portion of long-term debt +€58,825

    up €58,825 (+78.9%), from €74,589 to €133,413

Income statement
  • Staff costs +€187,615

    up €187,615 (+8.7%), from €2.1m to €2.3m

  • Financial income +€62,154

    up €62,154 (+62,154%), from €100 to €62,254

  • Taxes -€44,937

    down €44,937 (-28.4%), from €158,329 to €113,392

  • Gross operating margin +€32,353

    up €32,353 (+1.1%), from €3.0m to €3.1m

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €392,283
Gross operating margin +€32,353
Staff costs -€187,615
Depreciation +€5,648
Financial income +€62,154
Financial charges +€18,642
Taxes +€44,937
Result 2025 €368,404
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€450,178
Investment -€611,567
Financing +€165,324
Cash 2024 €114,569
Net result for the year +€368,404
Depreciation +€195,983
Stocks and contracts -€32,755
Receivables within one year +€287,483
Deferred charges and accrued income -€72,999
Trade debts -€257,057
Tax, wage and social debts +€73,356
Other debts -€22,000
Accrued charges and deferred income -€90,236
Investment in fixed assets (net) -€611,567
Debts after one year +€474,499
Current portion of long-term debt +€58,825
Contributions, distributions and other -€368,000
Cash 2025 €118,505
brings cash intakes cash out
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €4,142,688 €4,380,478 +€237,790 +5.7%
Fixed assets 21/28 €1,105,284 €1,520,868 +€415,583 +37.6%
Intangible fixed assets 21 €0 - =
Tangible fixed assets 22/27 €1,102,794 €1,497,151 +€394,357 +35.8%
Land and buildings 22 €735,421 €629,012 -€106,409 -14.5%
Plant, machinery and equipment 23 €294,994 €835,016 +€540,022 +183%
Furniture and vehicles 24 €72,379 €33,123 -€39,256 -54.2%
Financial fixed assets 28 €2,490 €23,716 +€21,226 +852%
Current assets 29/58 €3,037,404 €2,859,610 -€177,793 -5.9%
Stocks and contracts in progress 3 €1,115,313 €1,148,068 +€32,755 +2.9%
Stocks 30/36 €1,115,313 €1,148,068 +€32,755 +2.9%
Amounts receivable within one year 40/41 €1,743,242 €1,455,759 -€287,483 -16.5%
Trade receivables 40 €1,653,350 €1,275,383 -€377,966 -22.9%
Other amounts receivable 41 €89,892 €180,376 +€90,484 +101%
Cash at bank and in hand 54/58 €114,569 €118,505 +€3,936 +3.4%
Deferred charges and accrued income 490/1 €64,279 €137,278 +€72,999 +114%
Total equity and liabilities 10/49 €4,142,688 €4,380,478 +€237,790 +5.7%
Equity 10/15 €779,754 €780,157 +€404 +0.1%
Contributions 10/11 €562,000 €562,000 = 0.0%
Capital 10 €562,000 €562,000 = 0.0%
Issued capital 100 €562,000 €562,000 = 0.0%
Reserves 13 €56,200 €56,200 = 0.0%
Non-distributable reserves 130/1 €56,200 €56,200 = 0.0%
Legal reserve 130 €56,200 €56,200 = 0.0%
Profit (loss) carried forward 14 €161,554 €161,957 +€404 +0.2%
Amounts payable 17/49 €3,362,934 €3,600,321 +€237,387 +7.1%
Amounts payable after more than one year 17 €372,545 €847,045 +€474,499 +127%
Financial debts 170/4 €372,545 €847,045 +€474,499 +127%
Amounts payable within one year 42/48 €2,765,046 €2,618,169 -€146,877 -5.3%
Current portion of amounts payable after more than one year 42 €74,589 €133,413 +€58,825 +78.9%
Trade debts 44 €2,056,886 €1,799,829 -€257,057 -12.5%
Suppliers 440/4 €2,056,886 €1,799,829 -€257,057 -12.5%
Taxes, remuneration and social security 45 €243,571 €316,927 +€73,356 +30.1%
Taxes 450/3 €58,330 €111,722 +€53,392 +91.5%
Remuneration and social security 454/9 €185,242 €205,205 +€19,964 +10.8%
Other amounts payable 47/48 €390,000 €368,000 -€22,000 -5.6%
Accrued charges and deferred income 492/3 €225,343 €135,107 -€90,236 -40.0%
Non-recurring operating income 76A €8,482 €33,976 +€25,494 +301%
Remuneration, social security and pensions 62 €2,147,713 €2,335,327 +€187,615 +8.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €201,632 €195,983 -€5,648 -2.8%
Non-recurring operating charges 66A €0 - =
Gross operating margin 9900 €3,030,005 €3,062,358 +€32,353 +1.1%
Operating profit (loss) 9901 €680,661 €531,047 -€149,613 -22.0%
Financial income 75/76B €100 €62,254 +€62,154 +62,154%
Recurring financial income 75 €100 €62,254 +€62,154 +62,154%
Financial charges 65/66B €130,148 €111,506 -€18,642 -14.3%
Recurring financial charges 65 €130,148 €111,506 -€18,642 -14.3%
Profit (loss) for the period before taxes 9903 €550,613 €481,796 -€68,817 -12.5%
Income taxes 67/77 €158,329 €113,392 -€44,937 -28.4%
Profit (loss) for the period 9904 €392,283 €368,404 -€23,880 -6.1%
Profit (loss) for the period to be appropriated 9905 €392,283 €368,404 -€23,880 -6.1%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€1.4m to €1.9m

Midpoint €1.6m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €780,157
Capitalised earnings €2.1m to €2.9m
Indication €1.4m to €1.9m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€780,157
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€780,157

Capitalised earnings

net result for the year (9904)
2025
€368,404
excluding non-recurring income and charges
€334,428
2024
€392,283
excluding non-recurring income and charges
€383,802
2023
€181,770
excluding non-recurring income and charges
€164,353
2022
€259,674
excluding non-recurring income and charges
€270,940
2021
€586,493
excluding non-recurring income and charges
€572,580
Average result, excluding non-recurring income and charges
€294,194
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€2.1m / €2.5m / €2.9m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 11 November 2026 via checked.be.